The prevalence of the metabolic syndrome among Arab Americans

被引:98
作者
Jaber, LA
Brown, MB
Hammad, A
Zhu, Q
Herman, WH
机构
[1] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48201 USA
[2] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[3] ACCESS, Ctr Community Hlth, Dearborn, MI USA
[4] Univ Michigan, Dept Internal Med & Epidemiol, Ann Arbor, MI USA
关键词
D O I
10.2337/diacare.27.1.234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To estimate the prevalence of the metabolic syndrome in Arab Americans by age, sex, and BMI and to examine the association between insulin resistance and each of the components of the metabolic syndrome. RESEARCH DESIGN AND METHODS - We studied a representative, cross-sectional, population-based sample of 542 Arab Americans aged 20-75 years. The metabolic syndrome was defined by Adult Treatment Panel III (ATP III) and World Health Organization (WHO) diagnostic criteria. Insulin resistance was estimated by homeostasis model assessment (HOMA-IR). RESULTS - The age-adjusted prevalence of the metabolic syndrome was 23% (95% Cl 19-26%) by the ATP III definition and 28% (24-32%) by the WHO definition. Although the prevalence increased significantly with age and BMI in both sexes by both definitions, differences in estimates were noted. With ATP III, the age-specific rates were similar for men and women aged 20-49 years but were significantly higher for women aged greater than or equal to50 years. With WHO, rates were higher for men than women aged 20-49 years and similar for those aged greater than or equal to50 years. The most common component of the metabolic syndrome in men and women was low HDL cholesterol with the ATP III and the presence of glucose intolerance and HOMA-IR with the WHO. Strong associations between HOMA-IR and individual components of the metabolic syndrome were observed. After fitting a model with HOMA-IR as the outcome, waist circumference, triglyceride level, and fasting plasma glucose level were significantly associated with HOMA-IR. CONCLUSIONS - The metabolic syndrome is common among Arab Americans and is related to modifiable risk factors.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 20 条
[1]   The metabolic syndrome in the West Bank population - An urban-rural comparison [J].
Abdul-Rahim, HF ;
Husseini, A ;
Bjertness, E ;
Giacaman, R ;
Gordon, NH ;
Jervell, J .
DIABETES CARE, 2001, 24 (02) :275-279
[2]   Prevalence of the metabolic syndrome among Omani adults [J].
Al-Lawati, JA ;
Mohammed, AJ ;
Al-Hinai, HQ ;
Jousilahti, P .
DIABETES CARE, 2003, 26 (06) :1781-1785
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]  
Balkau B, 1999, DIABETIC MED, V16, P442
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[9]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[10]   Components of the "metabolic syndrome" and incidence of type 2 diabetes [J].
Hanson, RL ;
Imperatore, G ;
Bennett, PH ;
Knowler, WC .
DIABETES, 2002, 51 (10) :3120-3127